MoneyWorks4Me

FDC - Quaterly Results

07 Aug 2024 Evaluate
The Revenue for the quarter ended  June 2024 of Rs. 6241.41 millions grew by 17.75 % from Rs. 5300.40 millions.A humble growth in net profit of 5.93% reported in the quarter ended June 2024 to Rs. 1149.89  millions from Rs. 1085.51 millions.The company reported a good operating profit of 1698.46 millions compared to 1497.90 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 6241.41 5300.40 17.75 6241.41 5300.40 17.75 19161.87 17770.32 7.83
Other Income 281.53 297.84 -5.48 281.53 297.84 -5.48 1032.16 539.12 91.45
PBIDT 1698.46 1497.90 13.39 1698.46 1497.90 13.39 4416.74 3084.87 43.17
Interest 12.92 10.38 24.47 12.92 10.38 24.47 40.00 40.39 -0.97
PBDT 1685.54 1487.52 13.31 1685.54 1487.52 13.31 4376.74 3044.48 43.76
Depreciation 109.95 95.88 14.67 109.95 95.88 14.67 397.29 387.58 2.51
PBT 1575.59 1391.64 13.22 1575.59 1391.64 13.22 3979.45 2656.90 49.78
TAX 425.70 306.13 39.06 425.70 306.13 39.06 907.82 647.25 40.26
Deferred Tax 65.70 1.13 5714.16 65.70 1.13 5714.16 51.63 -42.75 -220.77
PAT 1149.89 1085.51 5.93 1149.89 1085.51 5.93 3071.63 2009.65 52.84
Equity 162.81 165.91 -1.87 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 27.21 28.26 -3.71 27.21 28.26 -3.71 23.05 17.36 32.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..